Author

F.-C. Bidard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 2 Assay:DNA methylation· 2 Approach:experimental assay· 2 Research Focus:variant calling· 2 Assay:whole-genome sequencing· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1

Frequent Co-Authors

L. Cabel· 2 shared M.-H. Stern· 2 shared A. D. Schmitt· 1 shared A. Dahmani· 1 shared A. Noret· 1 shared A. Rampanou· 1 shared A. Salomon· 1 shared A. Vincent-Salomon· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

L. Cabel

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Deep Learning identifies new morphological patterns of Homologous Recombination Deficiency in luminal breast cancers from whole slide images.

T. Lazard, G. Bataillon, P. Naylor, T. Popova, F.-c. Bidard, D. Stoppa-Lyonnet, M.-H. Stern, E. Decenciere, T. Walter, A. Salomon

This study uses deep learning to identify new morphological patterns of HRD in luminal breast cancers from whole slide images, achieving high accuracy and enabling new hypotheses on phenotypic impacts.

bioRxiv · Sep 10, 2021Cancer Biology

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

G. Bianco, M. Coto Llerena, J. Gallon, S. Taha-Mehlitz, V. Kancherla, M. Konantz, S. Srivatsa, H. Montazeri, F. Panebianco, M. De Menna, V. Paradiso, C. Ercan, A. Dahmani, E. Montaudon, N. Beerenwinkel, , S. Piscuoglio

This study identifies GATA3 and MDM2 as synthetic lethal in ER-positive breast cancers, showing MDM2 inhibition can target GATA3-deficient tumors via the PI3K/Akt/mTOR pathway.

bioRxiv · May 18, 2020Cancer Biology

Spatial co-fragmentation pattern of cell-free DNA recapitulates in vivo chromatin organization and identifies tissues-of-origin

Y. Liu, T.-Y. Liu, D. E. Weinberg, B. W. White, C. J. De La Torre, C. L. Tan, A. D. Schmitt, S. Selvaraj, V. Tran, L. C. Laurent, L. Cabel, F.-C. Bidard, G. Putcha, I. S. Haque

The paper shows that fragment length patterns in cell-free DNA reflect in vivo chromatin organization and can identify tissues-of-origin.

bioRxiv · Oct 23, 2019 · PreprintGenomics

A single droplet digital PCR for ESR1 activating mutations detection in plasma

E. Jeannot, L. Darrigues, M. Michel, M.-H. Stern, J.-Y. Pierga, A. Rampanou, S. Melaabi, C. Benoist, I. Bieche, A. Vincent-Salomon, R. El Ayachy, A. Noret, N. Epaillard, L. Cabel, F.-C. Bidard, C. Proudhon

This paper develops a multiplex droplet digital PCR assay for detecting ESR1 activating mutations in plasma, showing high sensitivity and concordance with NGS data.

bioRxiv · Jan 8, 2019Cancer Biology